Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC δ-independent mechanism in human malignant tumor cells

Carcinogenesis

Volumn 30, Issue 5, 2009, Pages 729-736

  Lim, Jun Hee ^b   Park, Jong Wook ^b   Choi, Kyeong Sook ^b   Park, Yong Bok ^c   Kwon, Taeg Kyu ^a  

^a Keimyung University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 5; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MESSENGER RNA; PROTEIN KINASE C DELTA; ROTTLERIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN HT29; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG MECHANISM; DRUG SENSITIZATION; FLOW CYTOMETRY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING;

ACETOPHENONES; APOPTOSIS; BENZOPYRANS; CELL LINE; CELL LINE, TUMOR; DNA PRIMERS; ENZYME INHIBITORS; FLOW CYTOMETRY; GENES, REPORTER; GLOMERULAR MESANGIUM; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C-DELTA; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR CHOP; TRANSFECTION; UP-REGULATION;

EID: 65549101773     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn265     Document Type: Article

References (34)

1. MacFarlane,M. et al. (1997) Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272, 25417-25420.
2. Walczak,H. et al. (1997) TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J., 16, 5386-5397.
3. Hersey,P. et al. (2001) How melanoma cells evade trail-induced apoptosis. Nat. Rev. Cancer, 1, 142-150.
4. Ashkenazi,A. et al. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest., 104, 155-162.
5. Walczak,H. et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med., 5 157-163.
6. Kim,Y.H. et al. (2008) Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic. Biol. Med., 44, 1055-1068.
7. Kim,E.H. et al. (2008) Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/ enhancer-binding protein homologous protein-dependent DR5 up-regulation. Cancer Res., 68, 266-275.
8. Jung,E.M. et al. (2006) Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis, 27 2008-2017.
9. Yamaguchi,H. et al. (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem., 279, 45495-45502.
10. Yoshida,T. et al. (2005) Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein. Cancer Res., 65, 5662-5667.
11. Takimoto,R. et al. (2000) Wild-type p53 transactivates the KILLER/ DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene, 19, 1735-1743.
12. Wu,G.S. et al. (2000) KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death. Adv. Exp. Med. Biol., 465, 143-151.
13. Shetty,S. et al. (2005) Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol. Cell. Biol., 25, 5404-5416.
14. Soltoff,S.P. (2007) Rottlerin: An inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol. Sci., 28, 453-458.
15. Brodie,C. et al. (2003) Regulation of cell apoptosis by protein kinase c delta. Apoptosis, 8, 19-27.
16. Soltoff,S.P. (2001) Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J. Biol. Chem., 276, 37986-37992.
17. Tapia,J.A. et al. (2006) Rottlerin inhibits stimulated enzymatic secretion and several intracellular signaling transduction pathways in pancreatic acinar cells by a non-PKC-delta-dependent mechanism. Biochim. Biophys. Acta, 1763, 25-38.
18. Tillman,D.M. et al. (2003) Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res., 63, 5118-5125.
19. Kim,E.H. et al. (2005) Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene, 24, 838-849.
20. Kim,Y.H. et al. (2004) Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. Carcinogenesis, 25, 1813-1820.
21. Liao,Y.F. et al. (2005) The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade. Life Sci., 77 707-719.
22. Horinaka,M. et al. (2005) Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells. Oncogene, 24, 7180-7189.
23. Jung,E.M. et al. (2005) Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis, 26, 1905-1913.
24. Kim,H. et al. (2006) Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res., 66, 1740-1750.
25. Chen,J.J. et al. (2008) Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation. J. Immunol., 180, 8030-8039.
26. Lim,J.H. et al. (2008) Rottlerin induces pro-apoptotic endoplasmic reticulum stress through the protein kinase C-delta-independent pathway in human colon cancer cells. Apoptosis, 13, 1378-1385.
27. Beltinger,C. et al. (1999) Herpes simplex virus thymidine kinase/ ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc. Natl Acad. Sci. USA, 96, 8699-8704.
28. Fumarola,C. et al. (2001) Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis. Cell Death Differ., 8, 1004-1013.
29. Qiao,L. et al. (2001) Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: Inhibition of EGFR/ mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol. Biol. Cell, 12, 2629-2645.
30. Nagata,S. (1997) Apoptosis by death factor. Cell, 88, 355-365.
31. Sheridan,J.P. et al. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277, 818-821.
32. Wu,G.S. et al. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet., 17, 141-143.
33. Basu,A. et al. (2008) Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway. Cancer Res., 68 2795-2802.
34. Byun,H.S. et al. (2008) Prevention of TNF-induced necrotic cell death by rottlerin through a Nox1 NADPH oxidase. Exp. Mol. Med., 40, 186-195.